The role of ephrinB1 reverse signalling in osteogenic differentiation during skeletal development and osteoporosis
The role of ephrinB1 reverse signalling in osteogenic differentiation during skeletal development and osteoporosis
批准号:
nhmrc : 1083704
负责人:
Dr Agnieszka Arthur
金额:
$37.83万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 2017-12-31
中文摘要
目前的建议将确定ephrinB 1在骨质疏松症中发生的骨重建失调过程中的重要性,通过删除ephrinB 1在骨质疏松症小鼠模型中的定向成骨细胞前体细胞。从这一建议中获得的知识可能会转化为骨质疏松症患者的替代治疗策略,使用目前正在开发的Eph/ephrin靶向药物治疗癌症。
英文摘要
The present proposal will identify the importance of ephrinB1 during the deregulation of bone remodelling that occurs in osteoporosis, by deleting ephrinB1 in committed osteoblast precursor cells in a mouse model of osteoporosis. Knowledge gained from this proposal could potentially translate into alternative therapeutic treatment strategies for patients with osteoporosis with the use of Eph/ephrin targeted drugs currently being developed for cancer treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Notch1通路激活并上调ephrinB1表达在促骨肉瘤细胞“干性”及增加化疗耐药中的作用与机制
-
批准号:81802689
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2018
-
负责人:高天
-
依托单位: